PPARG and Insulin resistance: Considering the roles that inflammation, the insulin signaling pathway, and PPAR‐γ expression play in the pathogenesis of insulin resistance, we tentatively suggest that GPR50 is involved in regulating inflammation and insulin signaling; therefore, GPR50 may contribute positively to insulin resistance.